GH Optimization Research Kit — Complete Growth Hormone Axis Research
The GH Optimization Research Kit is an institutional growth-hormone-axis research procurement kit combining GHRH analogue (CJC-1295), selective GHRP (Ipamorelin), non-selective GHRP (GHRP-6), and second GHRH analogue (Sermorelin) for comprehensive GHRH/GHRP pathway research within a single institutional procurement.
Research Mechanism Coverage
The four-compound combination enables co-administration research across both GHRH receptor activation (CJC-1295 sustained + Sermorelin pulsatile) and GHS-R1a activation (Ipamorelin selective + GHRP-6 non-selective) — covering the major GH-axis research peptide classes within a single procurement.
Configuration Options
- Standard ($520): CJC 10mg + Ipa 10mg + GHRP-6 10mg + Sermorelin 5mg, x2 each
- Advanced ($895): x4 of each compound
- Extended Protocol ($1,650): x8 of each compound
Institutional minimum $500. Custom configurations available.
Research Use Only. For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing you confirm research-only intent. These products have not been evaluated by the FDA.


